We have another episode in a series of discussions with well-vetted guests from companies that I feel my community would benefit from hearing about
Today, I speak with Dr. Stephanie Venn Watson, a veterinary epidemiologist and the co-founder and co-CEO of Serafina Therapeutics. She has worked with the World Health Organization, DARPA, and the US Navy. She has over 70 patents and has authored more than 80 peer-reviewed scientific papers, and her discoveries have featured on NPR, Science Friday, BBC, NBC, and National Geographic. Her groundbreaking discoveries around the health benefits of C15:0 are the topic of a recent book.
In our conversation today, we explore longevity molecules and geno-protective molecules, why they matter, and how they work. We cover the basics of rapamycin and glucophage, then dig into the growing body of research on longevity and lifespan, specifically looking at C15:0, what it is, what it does, why it’s important, and how it’s the first essential fatty acid discovered in decades. We look at its wide-ranging pleiotropic effects on metabolic health, mood, sleep, the brain, gut, and immunity, as well as the signs of low C15:0 levels and the specific labs that can identify a deficiency. We also talk about the benefits of supplementation and improved bioavailability.
Since I have been taking C15:0 myself over the last four to five months and noticed improvements in my recovery and sleep, I’m excited to share this informative and helpful conversation, humbly dedicated to the essential saturated fatty acid, C15:0.
IN THIS EPISODE, YOU WILL LEARN:
• The role C15:0 plays in guiding the aging process and new findings about its benefits for the immune system, brain, and longevity
• C15:0’s emerging importance as a key player in metabolic balance
• What Dr. Venn-Watson’s animal studies revealed about the mechanisms of aging in humans
• Why women in midlife become more vulnerable to shifts in immune quality and cellular resilience
• The ways nutritional deficiencies can appear in blood markers long before symptoms develop
• What occurs with red blood cell stability and aging markers when C15:0 levels are too low
• Which biomarkers are now being considered early indicators of biological aging
• Formulation features of C15:0 that enhance its bioavailability
• The multiple bodily systems that can benefit from supplementing with C15:0
Connect with Cynthia Thurlow
Connect with Dr. Stephanie Venn-Watson
